Untangling the relationship between hemoglobin, peak troponin level, and mortality in patients with myocardial

Vojko Kanic1, Gregor Kompara1, David Suran1

  • 1Department of Cardiology and Angiology, Division of Internal Medicine, University Medical Center Maribor, Maribor, Slovenia.

Insights

Patients with lower admission hemoglobin (aHb) levels experience greater myocardial injury relative to heart size. Indexing troponin to body surface area (BSA) provides comparable cardiac injury information and may explain worse outcomes in low aHb patients.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Medicine

Background:

  • Patients with myocardial infarction (MI) and lower admission hemoglobin (aHb) levels exhibit poorer outcomes.
  • Hemoglobin levels correlate positively with body surface area (BSA) and cardiac mass.
  • This suggests lower aHb may indicate proportionally greater myocardial injury.

Purpose of the Study:

  • To investigate the relationship between admission hemoglobin (aHb) and troponin (Tn) normalized to body surface area (BSA) (Tn/BSA).
  • To assess the association between Tn/BSA and 30-day mortality in myocardial infarction (MI) patients.
  • To determine if indexing troponin to BSA offers a more comparable measure of cardiac injury relative to cardiac mass.

Main Methods:

  • Analysis of data from 6055 patients with myocardial infarction (MI).
  • Patients were stratified into seven groups based on admission hemoglobin (aHb) levels.
  • Statistical analysis assessed relationships between aHb, Tn/BSA, and 30-day mortality.

Main Results:

  • Higher aHb levels were associated with greater BSA.
  • A significant negative correlation was found between aHb and log10Tn/BSA across the entire cohort and in both sexes.
  • log10Tn/BSA was significantly associated with 30-day mortality in the overall group and separately in men and women.

Conclusions:

  • Similar peak troponin (Tn) values in patients with lower admission hemoglobin (aHb) indicate comparatively greater myocardial injury relative to cardiac mass.
  • This finding helps explain the worse outcomes observed in patients with lower aHb.
  • Indexing troponin to BSA is recommended for a more comparable assessment of cardiac injury relative to cardiac mass.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
383
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
247
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
52
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
103
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78